Research > ETFs > ETF / ETP Commentary > 

T. Rowe Price Makes the Midyear Case for Small-Caps

Small-cap stocks are drawing renewed attention from T. Rowe Price as the firm’s 2026 midyear outlook signals a broad shift in market leadership away from the largest technology companies.Key Takeaways: Mega-cap tech economics are shifting as AI infrastructure spending pressures free cash flow and return profiles. Small-cap and value stocks outperformed year-to-date as earnings growth spread beyond mega-cap names. TMSL returned 20.1% year-to-date while TACU applies active selection across 550 to 650 large-cap holdings. According to T. Rowe Price’s 2026 Midyear Market Outlook, the decade-long playbook of simply owning the benchmark’s largest companies is losing ground. Massive AI spending is changing the economics of mega-cap technology companies, pressuring free cash flow and altering return profiles. That shift creates room for active managers who can separate companies converting capital spending into durable earnings from those whose spending dilutes returns. Markets absorbed a difficult first half, including the Iran war, rising energy costs, sticky inflation, and supply chain disruptions, the report noted. Risk assets held up, backed by strong U.S. earnings and growth, but T. Rowe Price cautioned that investors risk mistaking resilience for calm. Central to the firm’s outlook is a change in where AI dollars are landing. Rather than flowing mainly to a handful of large platform companies, spending is now moving into power, data center infrastructure, electrical equipment, and cooling systems. In that context, AI has become less a technology story and more a broad industrial investment cycle.Small-Cap Stocks Gain as AI Dollars Spread WiderSmall-cap and value stocks outperformed year-to-date through May 29, even as AI-related companies remained key return drivers, the report noted. Small-caps offer more upside potential as earnings growth continues to spread. Two T. Rowe Price ETFs offer investors different ways to act on that shift. The T. Rowe Price Active Core U.S. Equity ETF (TACU) addresses concentration risk at the large-cap level. Built with between 550 and 650 holdings, TACU uses a combination of quantitative models and fundamental research to identify companies successfully converting AI investment into stronger returns, according to T. Rowe Price. TACU launched in December 2025, holds $14.2 million in assets, and has returned 10.2% year-to-date, per ETF Database. Designed for investors looking further down the market-cap scale, the T. Rowe Price Small-Mid Cap ETF (TMSL B+) targets companies with improving earnings, strong free cash flow, and attractive valuations, according to T. Rowe Price. TMSL connects to the report’s argument that AI spending flowing into physical infrastructure is creating earnings momentum beyond the mega-cap index. Launched in June 2023 and recently crossing its 3-year anniversary milestone, TMSL holds $2.43 billion in assets and has returned 20.1% year-to-date, per ETF Database. For more news, information, and analysis, visit our Active ETF Content Hub.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.